GGTI-2133
SIGMA/G5294 - ≥98% (HPLC), solid
Synonym: N-
CAS Number: 1217480-14-2
Empirical Formula (Hill Notation): C27H28N4O3 · C2HF3O2
Molecular Weight: 570.56
MDL Number: MFCD07776925
Linear Formula: C27H28N4O3 · C2HF3O2
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | solid |
| InChI | 1S/C27H28N4O3.C2HF3O2/c1- |
| InChI key | FXXUNOYBYJFSRB-UQIIZPHYSA |
| mp | 103-118.5 °C |
| Quality Level | 100 ![]() |
| SMILES string | OC(=O)C(F)(F)F.CC(C)C[C@H |
| solubility | DMSO: 25 mg/mL |
| H2O: insoluble | |
| storage temp. | −20°C |
| Application: | GGTI-2133 has been used • To understand the role of geranylgeranyl transferase in the regulation of CXC chemokine production and neutrophil recruitment in the lung. • To study the importance of geranylgeranylation in cell adhesion. • To measure ligand-induced ADP-ribosylation factor 6 (Arf6) activation in breast cancer cells. |
| Biochem/physiol Actions: | GGTase I mediates prenylation to induce the oncogenic functions of the Ras and Rho proteins. Thus, GGTase I inhibitors can be utilized as effective anticancer drugs. They are also useful in treating inflammation, atherosclerosis, multiple sclerosis and other diseases. |
| Biochem/physiol Actions: | GGTI-2133 is a cell-permeable non-thiol peptidomimetic that acts as a potent and selective inhibitor of geranylgeranyltransferase I (GGTase I; IC50 = 38 nM) with a 140-fold selectivity over farnesyltransferase (FTase; IC50 = 5.4 μM). |
| Packaging: | 1, 5 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H315 - H319 - H335 |
| Precautionary statements | P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| mp | 103-118.5 °C |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |


